Millions of women get painful UTIs that keep coming back. A new kind of antibiotic may help break the cycle
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
The American Journal of Managed Care6d
FDA Approves First New Class of Oral Antibiotics for Uncomplicated UTIs in Nearly 30 Years
The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...
Everyday Health on MSN4d
FDA Approves the First New UTI Antibiotic in Nearly 30 Years
This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...
US approves new antibiotic for urinary tract infections
US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 ...
Dentistry10d
Antibiotics in dentistry: prescribing remains ‘in excess’ of pre-pandemic levels
Prescribing levels of antibiotics across the UK have been slow to return to where they would have been if the pandemic had ...
McKnight's Long-Term Care News4d
FDA approves gepotidacin antibiotic for uncomplicated urinary tract infections
The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...
Failures of NHS urgent dental care will lead to an ‘antibiotic apocalypse’, dentists warn
Antibiotics are used as a substitute for treatment and could fuel antibiotic resistance, warns University of Manchester ...
WESH6d
FDA approves a new kind of oral antibiotic to treat urinary tract infections
the first in a new class of oral antibiotics for [uncomplicated UTIs] in nearly three decades, and to bring another option to patients given recurrent infections and rising rates of resistance to ...
WLWT6d
FDA approves a new kind of oral antibiotic to treat urinary tract infections
""We are proud to have developed Blujepa, the first in a new class of oral antibiotics for in nearly three decades, and to bring another option to patients given recurrent infections and rising ...